60 likes | 82 Views
A review of Txt2stop trials for smoking cessation support, showcasing promising outcomes and the need for strong implementation plans. Despite clear benefits for quitting smoking, many areas lack evidence for NCD interventions. The effectiveness of mobile technology-based interventions, especially for smoking cessation, requires well-designed trials.
E N D
Txt2stop - mobile phones based smoking cessation support A systematic review of mobile phone based trials for NCD Dr Cari Free Clinical Senior lecturer London School of Hygiene and Tropical Medicine
A randomised controlled trial of mobile phone based smoking cessation support Free C, Whittaker R, Knight R, Roberts I, Cairns J, Rogers A LSHTM CTRU Auckland QUIT (Bosworth R) Pilot funded by Cancer Research UK Main trial funded by the MRC
Smoking leading cause of preventable death • Txt2stop • 5800 smokers willing to quit • Allocated to txt2stop or control • Doubled biochemically validated quitting at six months • 10.7% txt2stop versus 4.9% control, relative risk 2.20 (95% CI 1.80 to 2.68), p<0.0001. • Implemented UK with over 48,000 users since 2012
Systematic review of trials of mobile technology based interventions for health or health care Promising results • Physical activity (only short term), hypertension • Appropriate disease management for providers (11/25 outcomes showed statistically significant benefits) Clear small benefits • appointment reminders. Mixed results few trials .e.g. asthma No clinically important benefits • Weight loss • Daily medication reminders RR 1.00 (95% CI 0.77 to 1.30)
Summary • Where there is good evidence of benefit strong implementation plans are needed e.g. smoking cessation • Lack of evidence in many areas for NCD • New and improved NCD interventions needed. • Well designed and adequately powered trials to demonstrate the effectiveness of interventions are needed in many areas.